Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Pulmonary Embolism | 109 | 2024 | 2568 | 15.820 |
Why?
|
Fibrin Fibrinogen Degradation Products | 21 | 2024 | 426 | 5.240 |
Why?
|
Venous Thromboembolism | 32 | 2024 | 1866 | 4.250 |
Why?
|
Thrombolytic Therapy | 22 | 2024 | 2055 | 2.580 |
Why?
|
Ventricular Dysfunction, Right | 13 | 2024 | 628 | 2.510 |
Why?
|
Patient Care Team | 13 | 2023 | 2515 | 2.400 |
Why?
|
Emergency Service, Hospital | 36 | 2024 | 7873 | 2.020 |
Why?
|
Anticoagulants | 19 | 2024 | 4785 | 1.710 |
Why?
|
Venous Thrombosis | 13 | 2021 | 1303 | 1.590 |
Why?
|
Fibrinolytic Agents | 10 | 2024 | 2073 | 1.200 |
Why?
|
Pulmonary Artery | 7 | 2024 | 1927 | 1.110 |
Why?
|
Acute Disease | 19 | 2024 | 7236 | 0.980 |
Why?
|
Oxygen Inhalation Therapy | 2 | 2024 | 410 | 0.890 |
Why?
|
Clinical Protocols | 3 | 2018 | 1436 | 0.820 |
Why?
|
Embolectomy | 5 | 2024 | 129 | 0.800 |
Why?
|
Thrombectomy | 6 | 2021 | 702 | 0.750 |
Why?
|
Ventricular Pressure | 2 | 2019 | 210 | 0.750 |
Why?
|
Vena Cava Filters | 4 | 2020 | 261 | 0.740 |
Why?
|
Tissue Plasminogen Activator | 5 | 2017 | 1163 | 0.710 |
Why?
|
Echocardiography | 15 | 2023 | 4987 | 0.700 |
Why?
|
Decision Support Techniques | 7 | 2019 | 1999 | 0.700 |
Why?
|
Hospital Rapid Response Team | 2 | 2018 | 54 | 0.690 |
Why?
|
Extracorporeal Membrane Oxygenation | 4 | 2020 | 1462 | 0.660 |
Why?
|
Partial Thromboplastin Time | 1 | 2019 | 204 | 0.640 |
Why?
|
Antifibrinolytic Agents | 3 | 2013 | 287 | 0.640 |
Why?
|
Cross-Over Studies | 1 | 2024 | 2079 | 0.610 |
Why?
|
Middle Aged | 77 | 2024 | 220603 | 0.590 |
Why?
|
Humans | 151 | 2024 | 760740 | 0.590 |
Why?
|
Female | 98 | 2024 | 392203 | 0.580 |
Why?
|
Dextrocardia | 1 | 2016 | 37 | 0.550 |
Why?
|
Prospective Studies | 40 | 2024 | 54364 | 0.540 |
Why?
|
Risk Assessment | 21 | 2024 | 23974 | 0.540 |
Why?
|
Probability | 8 | 2023 | 2475 | 0.540 |
Why?
|
Heparin | 3 | 2019 | 1632 | 0.530 |
Why?
|
Cardiac Output | 1 | 2019 | 831 | 0.530 |
Why?
|
Estrogen Replacement Therapy | 2 | 2024 | 1208 | 0.530 |
Why?
|
Genetic Predisposition to Disease | 12 | 2024 | 17878 | 0.530 |
Why?
|
Male | 90 | 2024 | 360402 | 0.520 |
Why?
|
Renal Insufficiency | 1 | 2022 | 808 | 0.520 |
Why?
|
Predictive Value of Tests | 13 | 2018 | 15250 | 0.520 |
Why?
|
Emergency Treatment | 3 | 2018 | 495 | 0.510 |
Why?
|
Radiation Injuries | 2 | 2013 | 1189 | 0.490 |
Why?
|
Flecainide | 1 | 2015 | 41 | 0.490 |
Why?
|
Aftercare | 2 | 2020 | 913 | 0.480 |
Why?
|
Intracranial Hemorrhages | 2 | 2017 | 809 | 0.480 |
Why?
|
Angiography | 4 | 2015 | 1595 | 0.470 |
Why?
|
Body Mass Index | 10 | 2022 | 12942 | 0.470 |
Why?
|
Secondary Prevention | 1 | 2020 | 1470 | 0.460 |
Why?
|
Risk Factors | 34 | 2024 | 74128 | 0.450 |
Why?
|
Respiratory Insufficiency | 1 | 2022 | 1230 | 0.430 |
Why?
|
Aged | 49 | 2024 | 169092 | 0.420 |
Why?
|
Emergency Medicine | 6 | 2019 | 1197 | 0.410 |
Why?
|
Genome-Wide Association Study | 13 | 2024 | 12661 | 0.410 |
Why?
|
Adiposity | 2 | 2022 | 1879 | 0.410 |
Why?
|
Thrombosis | 3 | 2022 | 2942 | 0.410 |
Why?
|
Adult | 59 | 2024 | 220995 | 0.400 |
Why?
|
Natriuretic Peptide, Brain | 3 | 2024 | 1723 | 0.380 |
Why?
|
Severity of Illness Index | 9 | 2021 | 15829 | 0.370 |
Why?
|
Metabolome | 1 | 2018 | 988 | 0.360 |
Why?
|
Anti-Arrhythmia Agents | 1 | 2015 | 763 | 0.360 |
Why?
|
Sensitivity and Specificity | 12 | 2018 | 14649 | 0.360 |
Why?
|
Pregnancy Complications, Cardiovascular | 1 | 2015 | 512 | 0.350 |
Why?
|
Blood Coagulation | 1 | 2016 | 1154 | 0.350 |
Why?
|
Electrocardiography | 4 | 2020 | 6346 | 0.340 |
Why?
|
Treatment Outcome | 21 | 2024 | 64572 | 0.330 |
Why?
|
Tomography, X-Ray Computed | 11 | 2024 | 20556 | 0.330 |
Why?
|
Intubation, Intratracheal | 3 | 2020 | 1331 | 0.330 |
Why?
|
Delivery of Health Care | 2 | 2019 | 5334 | 0.330 |
Why?
|
Age Factors | 6 | 2018 | 18381 | 0.320 |
Why?
|
Exercise | 3 | 2018 | 5886 | 0.320 |
Why?
|
Hemorrhage | 7 | 2024 | 3418 | 0.310 |
Why?
|
Ambulatory Care | 3 | 2022 | 2768 | 0.300 |
Why?
|
Paper | 1 | 2008 | 84 | 0.300 |
Why?
|
Unnecessary Procedures | 3 | 2016 | 414 | 0.290 |
Why?
|
Outpatients | 5 | 2018 | 1596 | 0.290 |
Why?
|
Quality of Health Care | 2 | 2013 | 4325 | 0.290 |
Why?
|
Retrospective Studies | 19 | 2023 | 80583 | 0.280 |
Why?
|
Carnitine | 2 | 2018 | 252 | 0.280 |
Why?
|
Risk | 6 | 2017 | 9603 | 0.280 |
Why?
|
Arthritis, Infectious | 1 | 2010 | 347 | 0.270 |
Why?
|
Medical Audit | 1 | 2008 | 453 | 0.270 |
Why?
|
Peptide Fragments | 2 | 2020 | 5109 | 0.260 |
Why?
|
Patient Preference | 1 | 2013 | 925 | 0.260 |
Why?
|
Diagnosis, Differential | 9 | 2019 | 12966 | 0.260 |
Why?
|
Computers, Handheld | 1 | 2008 | 210 | 0.260 |
Why?
|
Practice Guidelines as Topic | 3 | 2020 | 7390 | 0.260 |
Why?
|
Critical Care | 2 | 2020 | 2691 | 0.260 |
Why?
|
Heart Ventricles | 3 | 2023 | 3796 | 0.250 |
Why?
|
Logistic Models | 11 | 2018 | 13248 | 0.250 |
Why?
|
Libraries, Digital | 1 | 2005 | 6 | 0.250 |
Why?
|
Hospital Information Systems | 1 | 2008 | 394 | 0.250 |
Why?
|
Thromboembolism | 4 | 2020 | 991 | 0.250 |
Why?
|
Heart Failure | 2 | 2023 | 11670 | 0.240 |
Why?
|
Oxygen | 5 | 2024 | 4226 | 0.240 |
Why?
|
Heart Arrest | 1 | 2015 | 1513 | 0.240 |
Why?
|
Environmental Exposure | 2 | 2016 | 4483 | 0.230 |
Why?
|
Hospitals, General | 3 | 2016 | 798 | 0.230 |
Why?
|
Resource Allocation | 2 | 2016 | 350 | 0.230 |
Why?
|
Mendelian Randomization Analysis | 2 | 2022 | 1007 | 0.230 |
Why?
|
Decision Making | 2 | 2017 | 3919 | 0.220 |
Why?
|
Sarcoptes scabiei | 1 | 2003 | 3 | 0.220 |
Why?
|
Scabies | 1 | 2003 | 14 | 0.220 |
Why?
|
Intensive Care Units | 1 | 2017 | 3743 | 0.220 |
Why?
|
Hospitalization | 3 | 2020 | 10708 | 0.220 |
Why?
|
Heart | 2 | 2024 | 4403 | 0.220 |
Why?
|
Risk Adjustment | 2 | 2021 | 600 | 0.210 |
Why?
|
Massachusetts | 4 | 2021 | 8835 | 0.200 |
Why?
|
Case-Control Studies | 9 | 2024 | 22153 | 0.200 |
Why?
|
Hypertension, Pulmonary | 4 | 2021 | 1582 | 0.200 |
Why?
|
Medical Records Systems, Computerized | 1 | 2008 | 1191 | 0.190 |
Why?
|
Dyspnea | 4 | 2015 | 1347 | 0.190 |
Why?
|
Systole | 1 | 2023 | 935 | 0.180 |
Why?
|
Diastole | 1 | 2023 | 781 | 0.180 |
Why?
|
Disease Management | 2 | 2024 | 2506 | 0.180 |
Why?
|
Physicians | 1 | 2018 | 4583 | 0.170 |
Why?
|
Hospitals, Teaching | 2 | 2023 | 1155 | 0.170 |
Why?
|
Meningitis, Viral | 1 | 2019 | 50 | 0.170 |
Why?
|
Cardiology | 2 | 2024 | 1656 | 0.170 |
Why?
|
Hypotension | 2 | 2016 | 879 | 0.160 |
Why?
|
Critical Illness | 3 | 2020 | 2709 | 0.160 |
Why?
|
Fluid Therapy | 2 | 2020 | 577 | 0.160 |
Why?
|
Iopamidol | 1 | 2019 | 186 | 0.160 |
Why?
|
Longitudinal Studies | 5 | 2019 | 14599 | 0.160 |
Why?
|
Hemagglutination Tests | 1 | 2018 | 76 | 0.160 |
Why?
|
Plasminogen Activator Inhibitor 1 | 1 | 2019 | 277 | 0.160 |
Why?
|
C-Reactive Protein | 1 | 2010 | 3820 | 0.150 |
Why?
|
Exanthema | 1 | 2003 | 503 | 0.150 |
Why?
|
Radiography | 3 | 2014 | 6961 | 0.150 |
Why?
|
Diglycerides | 1 | 2018 | 177 | 0.150 |
Why?
|
Hypoxanthine | 1 | 2018 | 28 | 0.150 |
Why?
|
Polymorphism, Single Nucleotide | 9 | 2024 | 15908 | 0.150 |
Why?
|
Tricarboxylic Acids | 1 | 2018 | 26 | 0.150 |
Why?
|
Follow-Up Studies | 8 | 2019 | 39062 | 0.150 |
Why?
|
Prognosis | 4 | 2024 | 29601 | 0.150 |
Why?
|
Standard of Care | 2 | 2018 | 551 | 0.150 |
Why?
|
Hyperglycemic Hyperosmolar Nonketotic Coma | 1 | 2017 | 30 | 0.150 |
Why?
|
Biomedical Research | 2 | 2016 | 3426 | 0.140 |
Why?
|
Inosine | 1 | 2018 | 129 | 0.140 |
Why?
|
Odds Ratio | 7 | 2019 | 9644 | 0.140 |
Why?
|
Algorithms | 5 | 2024 | 14024 | 0.140 |
Why?
|
Herpes Zoster | 1 | 2019 | 253 | 0.140 |
Why?
|
Hospitals, University | 1 | 2019 | 565 | 0.140 |
Why?
|
Troponin | 1 | 2020 | 502 | 0.140 |
Why?
|
Vasoconstrictor Agents | 1 | 2020 | 654 | 0.140 |
Why?
|
Health Care Rationing | 2 | 2016 | 436 | 0.130 |
Why?
|
Research Design | 6 | 2018 | 6174 | 0.130 |
Why?
|
Primary Health Care | 1 | 2013 | 4677 | 0.130 |
Why?
|
Positive-Pressure Respiration | 1 | 2020 | 638 | 0.130 |
Why?
|
Vena Cava, Inferior | 1 | 2019 | 458 | 0.130 |
Why?
|
Randomized Controlled Trials as Topic | 3 | 2024 | 10203 | 0.130 |
Why?
|
Judgment | 1 | 2018 | 272 | 0.130 |
Why?
|
Ultrasonic Therapy | 1 | 2018 | 215 | 0.130 |
Why?
|
Microarray Analysis | 1 | 2019 | 748 | 0.130 |
Why?
|
Resuscitation | 1 | 2020 | 672 | 0.130 |
Why?
|
Porphyrins | 1 | 2018 | 352 | 0.130 |
Why?
|
Catheterization, Swan-Ganz | 1 | 2016 | 86 | 0.130 |
Why?
|
Alcohol Drinking | 2 | 2018 | 4028 | 0.130 |
Why?
|
Chest Pain | 3 | 2015 | 1091 | 0.130 |
Why?
|
Multivariate Analysis | 5 | 2016 | 12043 | 0.120 |
Why?
|
Research | 1 | 2024 | 1977 | 0.120 |
Why?
|
Academic Medical Centers | 3 | 2017 | 2756 | 0.120 |
Why?
|
Angiotensin Receptor Antagonists | 1 | 2022 | 1040 | 0.120 |
Why?
|
Incidental Findings | 1 | 2020 | 697 | 0.120 |
Why?
|
Lactic Acid | 1 | 2020 | 1139 | 0.120 |
Why?
|
Sodium Bicarbonate | 1 | 2015 | 60 | 0.120 |
Why?
|
Biological Assay | 1 | 2018 | 626 | 0.120 |
Why?
|
Angiotensin-Converting Enzyme Inhibitors | 1 | 2022 | 1517 | 0.120 |
Why?
|
Estrogens | 1 | 2022 | 1521 | 0.120 |
Why?
|
Tachycardia | 2 | 2015 | 597 | 0.120 |
Why?
|
Cohort Studies | 8 | 2024 | 41464 | 0.120 |
Why?
|
Obesity | 5 | 2022 | 12934 | 0.120 |
Why?
|
Point-of-Care Systems | 2 | 2020 | 1213 | 0.120 |
Why?
|
Acquired Immunodeficiency Syndrome | 1 | 2003 | 2197 | 0.120 |
Why?
|
Ventricular Function, Right | 4 | 2021 | 617 | 0.120 |
Why?
|
Purines | 1 | 2018 | 606 | 0.120 |
Why?
|
Drug Administration Schedule | 2 | 2019 | 4845 | 0.120 |
Why?
|
Exercise Tolerance | 2 | 2018 | 836 | 0.110 |
Why?
|
Patient Transfer | 1 | 2021 | 793 | 0.110 |
Why?
|
Aged, 80 and over | 10 | 2022 | 58919 | 0.110 |
Why?
|
Fibrinolysis | 1 | 2015 | 331 | 0.110 |
Why?
|
Hemoptysis | 1 | 2015 | 151 | 0.110 |
Why?
|
United States | 19 | 2021 | 72292 | 0.110 |
Why?
|
Pulmonary Medicine | 1 | 2016 | 221 | 0.110 |
Why?
|
Sexually Transmitted Diseases | 1 | 2019 | 661 | 0.110 |
Why?
|
Double-Blind Method | 3 | 2024 | 12333 | 0.110 |
Why?
|
Smoking | 4 | 2019 | 9054 | 0.110 |
Why?
|
Disease Progression | 3 | 2017 | 13495 | 0.110 |
Why?
|
Consciousness Disorders | 1 | 2017 | 441 | 0.110 |
Why?
|
Postmenopause | 1 | 2022 | 2511 | 0.100 |
Why?
|
Contraceptives, Oral | 1 | 2015 | 553 | 0.100 |
Why?
|
Education, Medical, Graduate | 1 | 2005 | 2373 | 0.100 |
Why?
|
Catheterization | 1 | 2018 | 1428 | 0.100 |
Why?
|
Hematology | 1 | 2016 | 243 | 0.100 |
Why?
|
Postoperative Hemorrhage | 1 | 2016 | 414 | 0.100 |
Why?
|
Antiviral Agents | 2 | 2022 | 3037 | 0.100 |
Why?
|
Fat Emulsions, Intravenous | 1 | 2015 | 314 | 0.100 |
Why?
|
Metabolomics | 2 | 2018 | 1656 | 0.100 |
Why?
|
Hemoglobins | 1 | 2018 | 1524 | 0.100 |
Why?
|
Heparin, Low-Molecular-Weight | 1 | 2013 | 344 | 0.100 |
Why?
|
Syncope | 1 | 2014 | 428 | 0.100 |
Why?
|
Nitric Oxide | 1 | 2020 | 2135 | 0.090 |
Why?
|
Lower Extremity | 2 | 2020 | 1200 | 0.090 |
Why?
|
Death, Sudden, Cardiac | 1 | 2019 | 1551 | 0.090 |
Why?
|
Time Factors | 7 | 2018 | 39908 | 0.090 |
Why?
|
Radiography, Thoracic | 1 | 2018 | 1302 | 0.090 |
Why?
|
Vascular Diseases | 1 | 2019 | 1159 | 0.090 |
Why?
|
Quality-Adjusted Life Years | 1 | 2017 | 1723 | 0.090 |
Why?
|
Respiratory Sounds | 1 | 2015 | 702 | 0.090 |
Why?
|
Organizational Innovation | 1 | 2014 | 537 | 0.090 |
Why?
|
Young Adult | 8 | 2021 | 59191 | 0.090 |
Why?
|
Health Resources | 1 | 2016 | 934 | 0.090 |
Why?
|
Advanced Cardiac Life Support | 1 | 2011 | 78 | 0.090 |
Why?
|
Genetic Loci | 1 | 2019 | 2624 | 0.090 |
Why?
|
Exercise Test | 1 | 2018 | 2127 | 0.090 |
Why?
|
ROC Curve | 2 | 2016 | 3575 | 0.090 |
Why?
|
Fatty Acids | 1 | 2018 | 1808 | 0.090 |
Why?
|
Enzyme-Linked Immunosorbent Assay | 2 | 2008 | 3798 | 0.080 |
Why?
|
Contrast Media | 2 | 2021 | 5305 | 0.080 |
Why?
|
Ventricular Dysfunction, Left | 1 | 2020 | 2118 | 0.080 |
Why?
|
Length of Stay | 3 | 2021 | 6418 | 0.080 |
Why?
|
Thoracic Surgery | 1 | 2016 | 722 | 0.080 |
Why?
|
Blood Sedimentation | 1 | 2010 | 235 | 0.080 |
Why?
|
Quality of Life | 6 | 2018 | 13359 | 0.080 |
Why?
|
Clinical Competence | 1 | 2005 | 4790 | 0.080 |
Why?
|
Membrane Transport Proteins | 1 | 2015 | 1034 | 0.080 |
Why?
|
Alleles | 2 | 2019 | 6861 | 0.080 |
Why?
|
Weight Gain | 1 | 2018 | 2349 | 0.080 |
Why?
|
ABO Blood-Group System | 1 | 2010 | 380 | 0.070 |
Why?
|
Models, Genetic | 1 | 2018 | 3431 | 0.070 |
Why?
|
Immobilization | 1 | 2009 | 229 | 0.070 |
Why?
|
Wounds and Injuries | 1 | 2020 | 2492 | 0.070 |
Why?
|
Quality Improvement | 2 | 2014 | 3801 | 0.070 |
Why?
|
Internship and Residency | 2 | 2005 | 5878 | 0.070 |
Why?
|
Time and Motion Studies | 1 | 2008 | 143 | 0.070 |
Why?
|
Patient Discharge | 2 | 2018 | 3442 | 0.070 |
Why?
|
Overweight | 1 | 2018 | 2417 | 0.070 |
Why?
|
Geriatric Assessment | 1 | 2015 | 1411 | 0.070 |
Why?
|
Accidental Falls | 1 | 2015 | 1067 | 0.070 |
Why?
|
Protective Clothing | 1 | 2007 | 103 | 0.070 |
Why?
|
Food | 1 | 2011 | 768 | 0.070 |
Why?
|
Genetic Variation | 2 | 2024 | 6561 | 0.070 |
Why?
|
Poisson Distribution | 1 | 2008 | 504 | 0.070 |
Why?
|
Sex Factors | 2 | 2018 | 10549 | 0.070 |
Why?
|
High-Throughput Nucleotide Sequencing | 1 | 2019 | 3634 | 0.070 |
Why?
|
Health Care Surveys | 1 | 2013 | 2422 | 0.070 |
Why?
|
Ultrasonography | 2 | 2020 | 5965 | 0.070 |
Why?
|
Medical History Taking | 1 | 2010 | 773 | 0.060 |
Why?
|
Pericarditis, Constrictive | 1 | 2005 | 46 | 0.060 |
Why?
|
Pericardiectomy | 1 | 2005 | 46 | 0.060 |
Why?
|
Endovascular Procedures | 1 | 2019 | 2182 | 0.060 |
Why?
|
Respiration, Artificial | 2 | 2021 | 2630 | 0.060 |
Why?
|
Laryngoscopes | 1 | 2007 | 146 | 0.060 |
Why?
|
Technology Assessment, Biomedical | 1 | 2008 | 306 | 0.060 |
Why?
|
Nasal Decongestants | 1 | 2005 | 29 | 0.060 |
Why?
|
Sympathomimetics | 1 | 2005 | 57 | 0.060 |
Why?
|
Neoplasms | 1 | 2014 | 22131 | 0.060 |
Why?
|
Ephedrine | 1 | 2005 | 52 | 0.060 |
Why?
|
Quality Control | 1 | 2008 | 831 | 0.060 |
Why?
|
Guideline Adherence | 1 | 2015 | 2218 | 0.060 |
Why?
|
Coronary Disease | 1 | 2019 | 5911 | 0.060 |
Why?
|
Consensus | 3 | 2019 | 3117 | 0.060 |
Why?
|
Proportional Hazards Models | 5 | 2018 | 12448 | 0.060 |
Why?
|
Membrane Glycoproteins | 1 | 2015 | 3688 | 0.060 |
Why?
|
Evidence-Based Medicine | 1 | 2016 | 3680 | 0.060 |
Why?
|
Pregnancy | 3 | 2015 | 29869 | 0.060 |
Why?
|
Boston | 2 | 2008 | 9313 | 0.060 |
Why?
|
Leg | 1 | 2009 | 1087 | 0.060 |
Why?
|
Physical Examination | 1 | 2010 | 1254 | 0.060 |
Why?
|
Surgical Procedures, Operative | 1 | 2015 | 1924 | 0.050 |
Why?
|
Ivermectin | 1 | 2003 | 46 | 0.050 |
Why?
|
Blood Pressure | 2 | 2021 | 8473 | 0.050 |
Why?
|
Particulate Matter | 1 | 2015 | 2602 | 0.050 |
Why?
|
Altitude | 1 | 2004 | 163 | 0.050 |
Why?
|
Diagnosis, Computer-Assisted | 1 | 2008 | 709 | 0.050 |
Why?
|
Contraceptives, Oral, Hormonal | 1 | 2024 | 190 | 0.050 |
Why?
|
Comorbidity | 4 | 2018 | 10507 | 0.050 |
Why?
|
Physical Exertion | 1 | 2005 | 668 | 0.050 |
Why?
|
Statistics as Topic | 1 | 2009 | 2358 | 0.050 |
Why?
|
Diagnostic Imaging | 1 | 2016 | 3527 | 0.050 |
Why?
|
Lung | 1 | 2021 | 9999 | 0.050 |
Why?
|
Pregnancy Complications, Hematologic | 1 | 2004 | 180 | 0.050 |
Why?
|
Radiology | 1 | 2016 | 2113 | 0.050 |
Why?
|
User-Computer Interface | 1 | 2008 | 1397 | 0.050 |
Why?
|
Bibliometrics | 1 | 2005 | 352 | 0.050 |
Why?
|
Stroke Volume | 1 | 2015 | 5486 | 0.050 |
Why?
|
Arrhythmias, Cardiac | 1 | 2011 | 2234 | 0.050 |
Why?
|
Survival Analysis | 2 | 2011 | 10072 | 0.050 |
Why?
|
Canada | 1 | 2005 | 2120 | 0.040 |
Why?
|
Models, Theoretical | 2 | 2016 | 3567 | 0.040 |
Why?
|
Feeding Behavior | 1 | 2011 | 3183 | 0.040 |
Why?
|
Testosterone Congeners | 1 | 2019 | 62 | 0.040 |
Why?
|
Internationality | 1 | 2005 | 1000 | 0.040 |
Why?
|
Decision Trees | 1 | 2021 | 504 | 0.040 |
Why?
|
Motor Activity | 1 | 2009 | 2714 | 0.040 |
Why?
|
Acyclovir | 1 | 2019 | 267 | 0.040 |
Why?
|
Troponin T | 1 | 2023 | 780 | 0.040 |
Why?
|
Iodine | 1 | 2021 | 287 | 0.040 |
Why?
|
Databases, Factual | 3 | 2021 | 7963 | 0.040 |
Why?
|
Recurrence | 1 | 2011 | 8426 | 0.040 |
Why?
|
Stress Disorders, Post-Traumatic | 1 | 2016 | 4575 | 0.040 |
Why?
|
Pulmonary Circulation | 1 | 2021 | 737 | 0.040 |
Why?
|
Patient Care Management | 1 | 2021 | 302 | 0.040 |
Why?
|
Genotype | 3 | 2019 | 12977 | 0.040 |
Why?
|
Tricuspid Valve | 1 | 2021 | 409 | 0.040 |
Why?
|
Inflammation | 1 | 2017 | 10759 | 0.040 |
Why?
|
Home Care Services | 1 | 2024 | 648 | 0.040 |
Why?
|
Hypertrophy, Right Ventricular | 1 | 2018 | 109 | 0.040 |
Why?
|
Convalescence | 1 | 2017 | 106 | 0.040 |
Why?
|
Emergencies | 1 | 2024 | 1217 | 0.040 |
Why?
|
Recovery of Function | 2 | 2018 | 2977 | 0.040 |
Why?
|
Fetal Blood | 1 | 2004 | 1347 | 0.040 |
Why?
|
Cerebral Hemorrhage | 1 | 2008 | 2642 | 0.030 |
Why?
|
Cough | 1 | 2021 | 595 | 0.030 |
Why?
|
Group Processes | 1 | 2018 | 228 | 0.030 |
Why?
|
Cross-Sectional Studies | 1 | 2018 | 26065 | 0.030 |
Why?
|
Osmolar Concentration | 1 | 2017 | 659 | 0.030 |
Why?
|
Postthrombotic Syndrome | 1 | 2016 | 28 | 0.030 |
Why?
|
Fellowships and Scholarships | 1 | 2005 | 1116 | 0.030 |
Why?
|
Hospital Bed Capacity | 1 | 2017 | 206 | 0.030 |
Why?
|
Sample Size | 1 | 2019 | 838 | 0.030 |
Why?
|
France | 1 | 2016 | 492 | 0.030 |
Why?
|
American Heart Association | 1 | 2019 | 1039 | 0.030 |
Why?
|
Pilot Projects | 1 | 2008 | 8619 | 0.030 |
Why?
|
Anemia | 1 | 2004 | 1504 | 0.030 |
Why?
|
Coronary Artery Disease | 1 | 2014 | 6403 | 0.030 |
Why?
|
Quantitative Trait Loci | 1 | 2022 | 2112 | 0.030 |
Why?
|
Organizational Objectives | 1 | 2016 | 426 | 0.030 |
Why?
|
Echocardiography, Doppler | 1 | 2018 | 893 | 0.030 |
Why?
|
Single-Blind Method | 1 | 2018 | 1575 | 0.030 |
Why?
|
Confidence Intervals | 2 | 2010 | 2925 | 0.030 |
Why?
|
Peripheral Vascular Diseases | 1 | 2016 | 488 | 0.030 |
Why?
|
Abdominal Pain | 1 | 2020 | 1070 | 0.030 |
Why?
|
Diet | 1 | 2011 | 8049 | 0.030 |
Why?
|
Models, Organizational | 1 | 2016 | 544 | 0.030 |
Why?
|
Fever | 1 | 2021 | 1618 | 0.030 |
Why?
|
Cardiovascular Diseases | 1 | 2019 | 15498 | 0.030 |
Why?
|
Hospitals, Urban | 1 | 2015 | 500 | 0.030 |
Why?
|
Area Under Curve | 1 | 2016 | 1635 | 0.030 |
Why?
|
Adolescent | 2 | 2018 | 88247 | 0.020 |
Why?
|
Gene Frequency | 1 | 2019 | 3601 | 0.020 |
Why?
|
Shock | 1 | 2014 | 314 | 0.020 |
Why?
|
Oxygen Consumption | 1 | 2018 | 1866 | 0.020 |
Why?
|
Vasodilator Agents | 1 | 2015 | 973 | 0.020 |
Why?
|
Interdisciplinary Communication | 1 | 2016 | 928 | 0.020 |
Why?
|
Particle Size | 1 | 2015 | 1648 | 0.020 |
Why?
|
Chi-Square Distribution | 1 | 2016 | 3410 | 0.020 |
Why?
|
Myocardial Infarction | 2 | 2016 | 11458 | 0.020 |
Why?
|
Aging | 1 | 2009 | 8700 | 0.020 |
Why?
|
United States Food and Drug Administration | 1 | 2018 | 1661 | 0.020 |
Why?
|
Cerebrovascular Disorders | 1 | 2016 | 1474 | 0.020 |
Why?
|
Hyperglycemia | 1 | 2017 | 1375 | 0.020 |
Why?
|
Medicare | 2 | 2018 | 6774 | 0.020 |
Why?
|
Medicine | 1 | 2017 | 942 | 0.020 |
Why?
|
Principal Component Analysis | 1 | 2011 | 943 | 0.020 |
Why?
|
Incidence | 2 | 2017 | 21339 | 0.020 |
Why?
|
Bundle-Branch Block | 1 | 2009 | 276 | 0.020 |
Why?
|
Patient Selection | 1 | 2019 | 4237 | 0.020 |
Why?
|
Referral and Consultation | 1 | 2020 | 3599 | 0.020 |
Why?
|
Ventricular Function, Left | 1 | 2020 | 3873 | 0.020 |
Why?
|
Thrombophilia | 1 | 2010 | 306 | 0.020 |
Why?
|
False Negative Reactions | 1 | 2008 | 573 | 0.020 |
Why?
|
Hospital Mortality | 1 | 2021 | 5292 | 0.020 |
Why?
|
Inpatients | 1 | 2018 | 2545 | 0.020 |
Why?
|
Regression Analysis | 1 | 2016 | 6339 | 0.020 |
Why?
|
Genomics | 1 | 2022 | 5822 | 0.020 |
Why?
|
Likelihood Functions | 1 | 2009 | 991 | 0.020 |
Why?
|
Mortality | 1 | 2016 | 2899 | 0.020 |
Why?
|
Mass Screening | 1 | 2021 | 5425 | 0.020 |
Why?
|
Emergency Medical Services | 1 | 2016 | 1921 | 0.020 |
Why?
|
Hypoglycemic Agents | 1 | 2017 | 3085 | 0.020 |
Why?
|
Registries | 1 | 2021 | 8209 | 0.010 |
Why?
|
Health Status | 1 | 2018 | 4076 | 0.010 |
Why?
|
Coronary Vasospasm | 1 | 2005 | 81 | 0.010 |
Why?
|
Nonprescription Drugs | 1 | 2005 | 118 | 0.010 |
Why?
|
Infant, Newborn | 1 | 2004 | 26183 | 0.010 |
Why?
|
Animals | 3 | 2019 | 168202 | 0.010 |
Why?
|
Drug Therapy, Combination | 1 | 2013 | 6305 | 0.010 |
Why?
|
Coronavirus Infections | 1 | 2021 | 3088 | 0.010 |
Why?
|
Insulin | 1 | 2017 | 6593 | 0.010 |
Why?
|
Travel | 1 | 2009 | 796 | 0.010 |
Why?
|
Hematocrit | 1 | 2004 | 623 | 0.010 |
Why?
|
Prevalence | 2 | 2012 | 15702 | 0.010 |
Why?
|
Air Pollution | 1 | 2015 | 2355 | 0.010 |
Why?
|
Mice, Inbred C57BL | 1 | 2019 | 22117 | 0.010 |
Why?
|
Peru | 1 | 2004 | 890 | 0.010 |
Why?
|
Oximetry | 1 | 2004 | 459 | 0.010 |
Why?
|
Acetaminophen | 1 | 2005 | 555 | 0.010 |
Why?
|
Diabetes Mellitus | 1 | 2019 | 5838 | 0.010 |
Why?
|
Warfarin | 1 | 2008 | 1477 | 0.010 |
Why?
|
Kaplan-Meier Estimate | 1 | 2010 | 6473 | 0.010 |
Why?
|
Drug Combinations | 1 | 2005 | 2048 | 0.010 |
Why?
|
Phenotype | 1 | 2016 | 16572 | 0.010 |
Why?
|
Respiration | 1 | 2004 | 1656 | 0.010 |
Why?
|
Bayes Theorem | 1 | 2005 | 2327 | 0.010 |
Why?
|
Mice | 1 | 2019 | 81368 | 0.010 |
Why?
|
Public Health | 1 | 2005 | 2671 | 0.010 |
Why?
|
Curriculum | 1 | 2005 | 3739 | 0.010 |
Why?
|